Combes Robert, Grindon Christina, Cronin Mark T D, Roberts David W, Garrod John F
FRAME, Nottingham, UK.
Altern Lab Anim. 2008 Oct;36 Suppl 1:91-109. doi: 10.1177/026119290803601s08.
Liverpool John Moores University and FRAME conducted a joint research project, sponsored by Defra, on the status of alternatives to animal testing with regard to the European Union REACH (Registration, Evaluation and Authorisation of Chemicals) system for the safety testing and risk assessment of chemicals. The project covered all the main toxicity endpoints associated with REACH. This paper focuses on the use of alternative (non-animal) methods (both in vitro and in silico) for acute systemic toxicity and toxicokinetic testing. The paper reviews in vitro tests based on basal cytotoxicity and target organ toxicity, along with QSAR models and expert systems available for this endpoint. The use of PBPK modelling for the prediction of ADME properties is also discussed. These tests are then incorporated into a decision-tree style, integrated testing strategy, which also includes the use of refined in vivo acute toxicity tests, as a last resort. The implementation of the strategy is intended to minimise the use of animals in the testing of acute systemic toxicity and toxicokinetics, whilst satisfying the scientific and logistical demands of the EU REACH legislation.
利物浦约翰摩尔斯大学和FRAME在英国环境、食品和农村事务部的资助下,开展了一个联合研究项目,研究关于欧盟化学品注册、评估、授权和限制(REACH)体系中化学品安全测试和风险评估的动物试验替代方法的现状。该项目涵盖了与REACH相关的所有主要毒性终点。本文重点关注用于急性全身毒性和毒代动力学测试的替代(非动物)方法(包括体外和计算机模拟方法)。本文回顾了基于基础细胞毒性和靶器官毒性的体外试验,以及可用于该终点的定量构效关系(QSAR)模型和专家系统。还讨论了使用生理药代动力学(PBPK)模型预测药物吸收、分布、代谢和排泄(ADME)特性。然后将这些试验纳入决策树式的综合测试策略,该策略还包括在万不得已时使用改进的体内急性毒性试验。该策略的实施旨在尽量减少急性全身毒性和毒代动力学测试中动物的使用,同时满足欧盟REACH法规的科学和后勤要求。